Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+47.0%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+47.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$8.37M-57.0%
2024$19.47M+28.0%
2023$15.22M+478.2%
2022$2.63M-
2021$0.00-
2020$0.00-
2019$0.00-